Neurometabolic Differences in Relapsing-Remitting Multiple Sclerosis: An Observational Study

In a study of 34 individuals with relapsing-remitting MS, researchers found higher levels of glutamate and glutamine+glutamate ratios in the frontal and parietal brain regions compared to healthy controls. These metabolites were linked to clinical symptoms like fatigue and anxiety, with specific regional differences in ratios observed.

Tags: #Other
Most relevant to: —
Source: Read original source (PMID 42785002)

This plain-English summary was written by AI from a published abstract and may contain errors. It is not medical advice. Read the original study and talk to your MS team before making decisions about treatment.

Why it matters

The findings suggest potential neurometabolic markers associated with MS symptoms, highlighting differences in brain chemistry in MS patients which could inform future research into understanding the disease.

What this does not prove

The exploratory nature of this study requires confirmation in larger cohorts and its findings may not apply to all people with RRMS due to the focused participant criteria related to fatigue.

Next milestone

No next milestone was established from the available source.

Study facts

Study design: Observational
Participants / samples: 34 · basis not reported
Randomised: Not reported
Controlled: Not reported
Primary endpoint met: Not reported
Relevant MS type: RRMS
Publication date: 2026-09-17
Evidence reviewed: Abstract only
Regulatory approval: Not reported
Research areas: Other

Original sources

Primary evidenceNeurometabolic brain changes in MS associated with fatigue and anxiety. ↗DOI: 10.1016/j.msard.2026.107930

Supporting passages (8)

study designIn this exploratory, hypothesis-generating study, we investigated regional neurometabolic abnormalities within the frontal and parietal regions of these tissue types and examined their preliminary associations with clinical measures, using in vivo magnetic resonance spectroscopic imaging (MRSI).

subjectsMETHODS: Neurometabolic differences between the frontal and parietal regions of WML, NAWM, and NAGM in people with relapsing-remitting MS (pw-RRMS; n=34; FSS≥ 4 inclusion criteria, indicating clinically significant fatigue) and healthy controls (HCs; n=10) were evaluated using MRSI at 3T.

sample sizepw-RRMS; n=34

research categoriesCONCLUSION: In this exploratory analysis, pw-RRMS exhibited region-specific neurochemical alterations associated with MS-related symptoms.

relevant ms typesCONCLUSION: In this exploratory analysis, pw-RRMS exhibited region-specific neurochemical alterations associated with MS-related symptoms.

publication date2026-09-17

findingshigher mean z-scores for glutamate (Glu) and glutamine+glutamate (Glx) ratios in frontal and parietal regions across all tissue types in pw-RRMS relative to HCs (all p < 0.0001). tCr ratios of Glu and Glx in NAWM and WML were higher in the frontal than in the parietal regions in pw-RRMS.

limitationsthe observed associations with fatigue may not readily generalise to the broader RRMS population.

AI assessment, not yet reviewed by a person · version 1 · Community votes are separate from evidence review.